Riskpilot← Back to searchSign inGet full accessIMOLOGI AS
ASActiveOrg 998770289Vestre Åstadvei 53, 1396 BillingstadComputer programming activities · NACE 6210Est. 20120 employees
Revenue 2024
NOK 0
EBITDA margin
—
+35% vs 2023
Equity ratio
83.6%
Financial strength
Net profit 2024
NOK -35K
+35% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -35K | +35% |
| Net profit | NOK -35K | +35% |
| Total assets | NOK 85K | -24% |
| Equity | NOK 71K | -33% |
| Employees | 0 | — |
Legal name
IMOLOGI AS
Org number
998770289
Legal form
Aksjeselskap
NACE code
6210 · Computer programming activities
Founded
7. september 2012
Share capital
NOK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene eller styrets leder alene.
Company purpose
Tilbyr it og ikt tjenster, samt tjenster som står i naturlig forbindesle med dette. Selskapet kan delta i annen virksomhet.
Address
Vestre Åstadvei 53, 1396 Billingstad
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 116 | 69 | 130 | 0 | 0 |
| Staff expenses | −1 | −1 | −0 | −0 | −0 |
| EBITDA | 42 | −31 | 5 | −54 | −35 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 42 | −31 | 5 | −54 | −35 |
| Net financials | 0 | 37 | −1 | 0 | 0 |
| Profit before tax | 42 | 5 | 4 | −54 | −35 |
| Tax | 9 | 4 | 1 | −0 | −0 |
| Net profit | 33 | 1 | 3 | −54 | −35 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 290 | 187 | 173 | 112 | 85 |
| Equity | 156 | 157 | 160 | 106 | 71 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 134 | 30 | 12 | 6 | 14 |
| Total debt | 134 | 30 | 12 | 6 | 14 |
EBITDA margin
-3529800.0%
This company
15.8%
Market median
-22340606% vs market
20202024
Equity ratio
83.6%
This company
38.2%
Market median
+119% vs market
20202024
Return on equity
-49.9%
This company
18.4%
Market median
-371% vs market
20202024
Net profit margin
-3529800.0%
This company
8.1%
Market median
-43577878% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BD Chief Executive Officer | Chief Executive Officer | 2012 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2012 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of IMOLOGI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Borgar Døhlen | Chief Executive Officer | 0 companies |
| Ivar Andre Ødegaard | Chairman | 0 companies |